New menopause drug a ‘game changer’ for one of main symptoms
Veoza offers another option to women who cannot take HRT
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.A new drug will be a “game changer” for menopausal women, an expert has said.
Veoza, which is set to be fully available in Ireland in April, is a non-hormonal medication designed to stop hot flushes and night sweats.
Campaigners say the daily tablet offers women an alternative to hormone replacement therapy (HRT) for the dreaded menopause symptoms.
Loretta Dignam, the founder of Menopause Hub clinics across Ireland, said its approval is a “hugely positive development”.
She said: “A UK study concluded that women experience a weekly total of 17 hot flushes and 11 night sweats – and this symptom alone can impact severely on sleep, mood, concentration, work and personal lives.
“I personally endured up to 39 hot flushes a day and then more at night with the duvet on and off over a three-year period, so I know first-hand how debilitating they can be, so this will be a game-changer.”
Ms Dignam said up to 80% of some 652,000 Irish women suffer symptoms of menopause.
These are primarily hot flushes and night sweats which are triggered by low oestrogen levels, affecting the part of the brain that regulates body temperature.
She said Veoza offers another option to women who cannot take HRT for various medical reasons or for those whose bodies will not absorb the hormones.
The medication has been approved by the Health Products Regulatory Authority but is not covered under the drug payment scheme, so it will be available privately at a cost of up to 70 euro per month.
The Menopause Hub said clinical trials in Europe found that after one month of treatment, the number of moderate to severe daily hot flushes was cut by 53% on average for participants.
It is not approved yet for those with active breast cancer.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments